Scotiabank Comments on Albemarle’s Q1 Earnings (NYSE:ALB)

Albemarle Co. (NYSE:ALB) – Analysts at Scotiabank issued their Q1 2025 EPS estimates for Albemarle in a research note issued to investors on Tuesday, February 18th. Scotiabank analyst B. Isaacson anticipates that the specialty chemicals company will earn ($0.14) per share for the quarter. Scotiabank currently has a “Sector Perform” rating and a $75.00 target price on the stock. The consensus estimate for Albemarle’s current full-year earnings is $1.44 per share. Scotiabank also issued estimates for Albemarle’s FY2026 earnings at $2.51 EPS.

ALB has been the subject of several other research reports. Robert W. Baird dropped their price objective on shares of Albemarle from $103.00 to $92.00 and set a “neutral” rating for the company in a research report on Wednesday, February 12th. Clarkson Capital began coverage on shares of Albemarle in a research note on Tuesday, January 14th. They issued a “buy” rating and a $112.00 target price for the company. Citigroup decreased their target price on shares of Albemarle from $115.00 to $85.00 and set a “neutral” rating for the company in a research note on Wednesday, February 12th. Oppenheimer decreased their target price on shares of Albemarle from $171.00 to $170.00 and set an “outperform” rating for the company in a research note on Friday, November 8th. Finally, Truist Financial decreased their target price on shares of Albemarle from $96.00 to $85.00 and set a “hold” rating for the company in a research note on Friday, February 14th. Two equities research analysts have rated the stock with a sell rating, fifteen have given a hold rating and six have issued a buy rating to the company. According to MarketBeat, Albemarle presently has an average rating of “Hold” and a consensus price target of $109.91.

Albemarle Price Performance

Albemarle stock opened at $83.55 on Thursday. Albemarle has a 52-week low of $71.97 and a 52-week high of $143.19. The firm has a fifty day moving average of $87.71 and a 200-day moving average of $92.14. The firm has a market capitalization of $9.82 billion, a P/E ratio of -7.46, a PEG ratio of 3.52 and a beta of 1.59. The company has a quick ratio of 1.19, a current ratio of 1.95 and a debt-to-equity ratio of 0.39.

Albemarle (NYSE:ALB) last released its quarterly earnings data on Wednesday, February 12th. The specialty chemicals company reported ($1.09) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.60) by ($0.49). Albemarle had a negative return on equity of 1.72% and a negative net margin of 21.93%.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. Charles Schwab Investment Management Inc. lifted its position in shares of Albemarle by 38.2% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,020,590 shares of the specialty chemicals company’s stock worth $96,660,000 after buying an additional 282,194 shares during the last quarter. Pacer Advisors Inc. increased its holdings in shares of Albemarle by 71.5% in the 4th quarter. Pacer Advisors Inc. now owns 14,948 shares of the specialty chemicals company’s stock worth $1,287,000 after acquiring an additional 6,234 shares during the period. Bristlecone Advisors LLC increased its holdings in shares of Albemarle by 20.5% in the 4th quarter. Bristlecone Advisors LLC now owns 28,824 shares of the specialty chemicals company’s stock worth $2,481,000 after acquiring an additional 4,899 shares during the period. Empower Advisory Group LLC increased its holdings in shares of Albemarle by 28.7% in the 3rd quarter. Empower Advisory Group LLC now owns 705,719 shares of the specialty chemicals company’s stock worth $66,839,000 after acquiring an additional 157,319 shares during the period. Finally, Nomura Asset Management Co. Ltd. increased its holdings in shares of Albemarle by 28.5% in the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 423,049 shares of the specialty chemicals company’s stock worth $40,067,000 after acquiring an additional 93,718 shares during the period. 92.87% of the stock is currently owned by institutional investors.

Insider Transactions at Albemarle

In other news, CEO J Kent Masters sold 2,525 shares of the firm’s stock in a transaction dated Thursday, December 5th. The shares were sold at an average price of $101.12, for a total value of $255,328.00. Following the transaction, the chief executive officer now directly owns 73,747 shares in the company, valued at approximately $7,457,296.64. This trade represents a 3.31 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 0.38% of the company’s stock.

Albemarle Company Profile

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.